Wan-Yong Feng, PhDVice President, Drug Metabolism and Pharmacokinetics
Dr. Wan-Yong Feng serves as the Vice President and Head of Drug Metabolism and Pharmacokinetics under the BioDuro Drug Discovery Business Unit with over 20 years of industrial experience in drug metabolism, pharmacokinetics, toxicokinetics, exploratory toxicity, bioanalytical chemistry, and mass spectrometry. Throughout his career, he has played a pivotal role in assessing candidate compound properties across ADME/PK/TK/Tox, lead optimization, preclinical candidate selection, preclinical and IND-enabling development and clinical Phase I trials across various therapeutic areas. Dr. Feng earned his PhD from the Chinese Academy of Science. He has authored 44 publications in peer-reviewed journals and book chapters, and served as a regular reviewer for the European Journal of Pharmaceutical Sciences as well as an editorial advisory board member for the Current Drug Discovery Technologies journals.
• PhD, Chinese Academy of Science
• 20+ years of industry experience
• Background: Chiron, Novartis, Bridge Laboratories, Dart Neuroscience
Home
